CREST-2 Study Finds Carotid Artery Stenting Superior to Medical Management for Asymptomatic Carotid Stenosis
ByAinvest
Monday, Nov 24, 2025 7:31 am ET1min read
NSPR--
InspireMD welcomes the publication of CREST-2 data in the New England Journal of Medicine, which shows positive clinical outcomes for carotid artery stenting in patients with asymptomatic carotid stenosis. The study demonstrated that stenting led to better outcomes than intensive medical management alone, with a decreased risk of stroke or death. InspireMD's CGuard Prime stent system is designed for the prevention of stroke, and the company believes that CREST-2 data validates its innovative mesh-protected platform.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet